An upregulation of DMBT1 has been proven in neonatal gastrointestinal diseases to be associated with inflammation (e.g., necrotizing enterocolitis) and infection in preterm patients (e.g., severe sepsis) independent from gestational age [17]. Here, DMBT1 is linked to gastrointestinal disease.